The goal of this project was to characterize changes in gene expression in response to the anti-cancer agent sapphyrin PCI-2050. Cultured A549 human lung cancer cells were treated with sapphyrin PCI-2
RNA-seq from RNA isolated from bone marrow or peripheral blood of newly diagnosed acute lymphoblastic leukemia patients on TotalXVI protocol Overall design: LC50 determination performed with concordan